APOBEC3G
MOLECULAR TARGETapolipoprotein B mRNA editing enzyme catalytic subunit 3G
APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) is targeted by 12 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting APOBEC3G
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 1.39 | 3 |
| 2 | Ampicillin Semi-synthetic derivative of penicillin that functions as | 1.10 | 2 |
| 3 | Anthralin | 1.10 | 2 |
| 4 | sulfameter | 1.10 | 2 |
| 5 | DEAD-box RNA Helicases | 0.69 | 1 |
| 6 | Thioctic Acid | 0.69 | 1 |
| 7 | Resveratrol | 0.69 | 1 |
| 8 | Cefotetan | 0.69 | 1 |
| 9 | Dimethylphenylpiperazinium Iodide | 0.69 | 1 |
| 10 | mg624 | 0.69 | 1 |
| 11 | streptonigrin | 0.69 | 1 |
| 12 | Thioctic Acid | 0.69 | 1 |
About APOBEC3G as a Drug Target
APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 12 compounds with documented APOBEC3G interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
APOBEC3G inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.